This issue of EuroIntervention opens with the rationale and design of the PROTECT IV trial before moving to original research on routine prasugrel or ticagrelor use in myocardial infarction; an acute coronary syndrome substudy of the OCCUPI Trial and blood pressure changes following renal denervation. This issue also includes a research correspondence on renal denervation and kidney disease and a flashlight that recounts a concertina effect mimicking plaque rupture on OCT; and more...